Abstractive Health vs Zus Health (2026)
Both start from the same insight, that the record worth summarising is not the one in front of you, and then they build different things on it. Zus assembles the longitudinal record: data from thousands of provider sites through the national networks, prescription fills, admission and discharge alerts, deduplicated and normalised, covering more than 320 million patients, with a published matching success rate of roughly 90 percent and the most detailed consent architecture in this index. Abstractive Health summarises that record and links every sentence back to the note it came from, and it published its own evaluation in a peer reviewed journal with a result that made its product look worse than physicians. Buy Zus if the problem is that the data is scattered. Buy Abstractive if the problem is that nobody can read what you already have.
- It published its own evaluation in a peer reviewed journal and the headline result was unfavourable to itself, finding its summaries marginally inferior to physicians on usefulness and safety. That is the strongest governance signal a vendor in this category can send.
- Verification is at sentence level. Every sentence of a summary links back to the source note it came from, which makes checking a specific claim a single action rather than a hunt through a reassembled record.
- The compliance position is complete rather than partial: SOC 2 Type II claimed for the company itself, a live public trust centre, a published business associate agreement and a published commercial ladder with real figures including a free tier.
- It is infrastructure rather than an application, so the assembled record can feed anything you build. Data arrives from thousands of provider sites through the national networks, prescription fills through Surescripts and admission and discharge alerts through named partners, then deduplicated and normalised to a common standard.
- The consent architecture is described in more detail than almost anything else in this index, gating access to third party data on the customer asserting an active treatment relationship rather than on an unspecified permission.
- It publishes a matching success rate of roughly 90 percent, which is an explicit admission that identity resolution is imperfect, and it links every summarised point directly to the underlying record.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abstractive Health and Zus Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abstractive Health | Zus Health |
|---|---|---|
| Primary category | Clinical Summarization & Chart Review | Healthcare Administrative Automation |
| Founded | 2022 | Not recorded |
| Headquarters | New York, NY, US | Not recorded |
| Website | abstractivehealth.com | zushealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Abstractive Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Zus Health, Abstractive Health grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Zus Health its top capability grade on EHR and Interoperability Depth. Set against Abstractive Health, Zus Health grades higher on FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Abstractive Health or Zus Health?
On the axes where the AI Health Index separates them, Abstractive Health grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency, and Zus Health grades higher on FDA and Regulatory Status. Abstractive Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Abstractive Health and Zus Health differ most?
The widest separation the AI Health Index records between Abstractive Health and Zus Health is on AI Centrality, where Abstractive Health grades A and Zus Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Abstractive Health and Zus Health grade the same?
The AI Health Index grades Abstractive Health and Zus Health the same on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and EHR and Interoperability Depth. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
These sit at different layers and can be complementary rather than exclusive: one assembles and normalises the record, the other summarises it with sentence level provenance. Zus publishes no security attestation and no trust centre across two passes, which is unusually consequential for a platform whose central design property is cross tenant data sharing, and it offers no customer hosted or single tenant option because the architecture is incompatible with one.
Zus publishes no pricing or pricing mechanism. Abstractive Health has named itself into a regulatory category it has not addressed: no clearance, device authorisation, pathway statement or exemption analysis was located.